ArticlePloS one2026
Association between diabetes mellitus and the risk of temporomandibular disorder: A nationwide population-based study.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the association between temporomandibular disorder (TMD) and diabetes mellitus (DM) and the potential risk factors of TMD using data from Taiwan's Longitudinal Generation Tracking Database. A cohort of 201,465 individuals newly diagnosed with diabetes mellitus (DM) and 805,860 matched non-DM controls was observed from 2000 to 2015. To evaluate the risk factors associated with the onset of temporomandibular disorders (TMD), Cox proportional hazards regression analysis was conducted. The Kaplan-Meier method, along with the log-rank test, was applied to assess the cumulative incidence of TMD among DM patients. Results from the Cox analysis indicated that having DM significantly increased the likelihood of developing TMD (adjusted hazard ratio: 2.543; p < 0.001). Furthermore, DM patients who also had rheumatoid arthritis or ankylosing spondylitis faced an even higher risk, being 4.289 and 4.021 times more likely, respectively, to develop TMD compared to those without these comorbidities (p < 0.001). Patients with DM had 2.543 times the probability of experiencing TMD events than patients without DM. Rheumatoid arthritis and ankylosing spondylitis were associated with the highest and second highest risk of patients with DM subsequently developing TMD. Our results provide crucial indications to prevent TMD in patients with DM and improve their quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.